Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts

Open access

Abstract

Generation of thick vascularized tissues that fully match the patient still remains an unmet challenge in cardiac tissue engineering. Here, a simple approach to 3D‐print thick, vascularized, and perfusable cardiac patches that completely match the immunological, cellular, biochemical, and anatomical properties of the patient is reported. To this end, a biopsy of an omental tissue is taken from patients. While the cells are reprogrammed to become pluripotent stem cells, and differentiated to cardiomyocytes and endothelial cells, the extracellular matrix is processed into a personalized hydrogel. Following, the two cell types are separately combined with hydrogels to form bioinks for the parenchymal cardiac tissue and blood vessels. The ability to print functional vascularized patches according to the patient's anatomy is demonstrated. Blood vessel architecture is further improved by mathematical modeling of oxygen transfer. The structure and function of the patches are studied in vitro, and cardiac cell morphology is assessed after transplantation, revealing elongated cardiomyocytes with massive actinin striation. Finally, as a proof of concept, cellularized human hearts with a natural architecture are printed. These results demonstrate the potential of the approach for engineering personalized tissues and organs, or for drug screening in an appropriate anatomical structure and patient‐specific biochemical microenvironment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.201900344

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Concept schematic. An omentum tissue is extracted from the patient and while the cells are separated from the matrix, the latter is processed into a personalized thermoresponsive hydrogel. The cells are reprogrammed to become pluripotent and are then differentiated to cardiomyocytes and endothelial cells, followed by encapsulation within the hydrogel to generate the bioinks used for printing. The bioinks are then printed to engineer vascularized patches and complex cellularized structures. The resulting autologous engineered tissue can be transplanted back into the patient, to repair or replace injured/diseased organs with low risk of rejection.
Figure 1 Concept schematic. An omentum tissue is extracted from the patient and while the cells are separated from the matrix, the latter is processed into a personalized thermoresponsive hydrogel. The cells are reprogrammed to become pluripotent and are then differentiated to cardiomyocytes and endothelial cells, followed by encapsulation within the hydrogel to generate the bioinks used for printing. The bioinks are then printed to engineer vascularized patches and complex cellularized structures. The resulting autologous engineered tissue can be transplanted back into the patient, to repair or replace injured/diseased organs with low risk of rejection.CC BY · PubMed Central
Figure 2 Bioinks characterization. A human omentum a) before and b) after decellularization. c) A personalized hydrogel at room temperature (left) and after gelation at 37 °C (right). d) A SEM image of the personalized hydrogel ultrastructural morphology, and e) a histogram of the fibers diameter. f) Rheology measurements of 1% w/v and 2.5% w/v omentum hydrogels, showing the gelation process upon incubation at 37 °C. g) Stromal cells originated from human omental tissues were reprogrammed to become pluripotent stem cells (red: OCT4, green: Ki67 and blue: nuclei). h) Differentiation to ECs as determined by CD31 (green) and vimentin staining (red). Differentiation to cardiac lineage: i) staining for sarcomeric actinin (red), j) staining for NKX2‐5 (red), and TNNT2 (green). Scale bars: (e) = 10 µm, (g,i,j) = 50 µm, (h) = 25 µm.
Figure 2 Bioinks characterization. A human omentum a) before and b) after decellularization. c) A personalized hydrogel at room temperature (left) and after gelation at 37 °C (right). d) A SEM image of the personalized hydrogel ultrastructural morphology, and e) a histogram of the fibers diameter. f) Rheology measurements of 1% w/v and 2.5% w/v omentum hydrogels, showing the gelation process upon incubation at 37 °C. g) Stromal cells originated from human omental tissues were reprogrammed to become pluripotent stem cells (red: OCT4, green: Ki67 and blue: nuclei). h) Differentiation to ECs as determined by CD31 (green) and vimentin staining (red). Differentiation to cardiac lineage: i) staining for sarcomeric actinin (red), j) staining for NKX2‐5 (red), and TNNT2 (green). Scale bars: (e) = 10 µm, (g,i,j) = 50 µm, (h) = 25 µm.CC BY · PubMed Central
Figure 3 Imaging of the heart and patch modeling. CT image of a) a human heart and b) left ventricle coronary arteries. c) A model of oxygen concentration profile in an engineered patch. d) Replanning of the model showed better oxygen diffusion, sufficient to support cell viability.
Figure 3 Imaging of the heart and patch modeling. CT image of a) a human heart and b) left ventricle coronary arteries. c) A model of oxygen concentration profile in an engineered patch. d) Replanning of the model showed better oxygen diffusion, sufficient to support cell viability.CC BY · PubMed Central
Figure 4 3D printing of personalized cardiac patches. a) A 3D model of the cardiac patch. b) A side view of the printing concept and the distinct cellular bioinks. c) A printed vascularized cardiac patch. d) Cell viability after printing. e) A printed blood vessel, continuously layered with GFP‐expressing ECs. f) A printed iPSCs‐derived cardiac patch where the blood vessels (CD31 in green) are seen in‐between the cardiac tissue (actinin in pink). g,h) Cross‐sections of a single lumen, showing the interactions of GFP‐expressing ECs and RFP‐expressing fibroblasts. i–k) Calcium imaging within a printed vascularized cardiac patch (separate regions of interest are represented in different colors. The white arrow represents signal direction). i) The lumen of a blood vessel can be easily observed in‐between the cardiac cells. j,k) Quantification of calcium transients across a lumen of the vascularized cardiac patch. l) Transplantation of the printed patch in between two layers of rat omentum. Dashed, white line highlights the borders of the patch. m–o) Sarcomeric actinin (red) and nuclei (blue) staining of sections from the explanted patch (panel (o) represents a high magnification of the marked area in (n). Scale bars: (c) = 1 cm, (e,g,h,l,m) = 100 µm, (f) = 500 µm, (n) = 50 µm, (o) = 25 µm.
Figure 4 3D printing of personalized cardiac patches. a) A 3D model of the cardiac patch. b) A side view of the printing concept and the distinct cellular bioinks. c) A printed vascularized cardiac patch. d) Cell viability after printing. e) A printed blood vessel, continuously layered with GFP‐expressing ECs. f) A printed iPSCs‐derived cardiac patch where the blood vessels (CD31 in green) are seen in‐between the cardiac tissue (actinin in pink). g,h) Cross‐sections of a single lumen, showing the interactions of GFP‐expressing ECs and RFP‐expressing fibroblasts. i–k) Calcium imaging within a printed vascularized cardiac patch (separate regions of interest are represented in different colors. The white arrow represents signal direction). i) The lumen of a blood vessel can be easily observed in‐between the cardiac cells. j,k) Quantification of calcium transients across a lumen of the vascularized cardiac patch. l) Transplantation of the printed patch in between two layers of rat omentum. Dashed, white line highlights the borders of the patch. m–o) Sarcomeric actinin (red) and nuclei (blue) staining of sections from the explanted patch (panel (o) represents a high magnification of the marked area in (n). Scale bars: (c) = 1 cm, (e,g,h,l,m) = 100 µm, (f) = 500 µm, (n) = 50 µm, (o) = 25 µm.CC BY · PubMed Central
Figure 5 Printing the personalized hydrogel in a supporting medium. a) A scheme of the 3D printing concept. The construct is free‐formed printed inside the support followed by incubation at 37 °C to crosslink the personalized hydrogel. Then, the structure can be safely extracted by an enzymatic or chemical degradation process of the support material and transferred into growth medium for culturing. b) A multilayered crisscross construct printed inside the support bath, and c) after its extraction. d) Cell viability before and after printing and after extraction. e) 3D confocal image of a double layered construct, printed in the support medium. f) A single strand of the personalized hydrogel within the support. g,h) Accurate, high resolution thick structures printed from the personalized hydrogel. Scale bars: (b) = 0.5 cm, (e) = 1 mm, (f) = 100 µm, (g,h) = 1 cm.
Figure 5 Printing the personalized hydrogel in a supporting medium. a) A scheme of the 3D printing concept. The construct is free‐formed printed inside the support followed by incubation at 37 °C to crosslink the personalized hydrogel. Then, the structure can be safely extracted by an enzymatic or chemical degradation process of the support material and transferred into growth medium for culturing. b) A multilayered crisscross construct printed inside the support bath, and c) after its extraction. d) Cell viability before and after printing and after extraction. e) 3D confocal image of a double layered construct, printed in the support medium. f) A single strand of the personalized hydrogel within the support. g,h) Accurate, high resolution thick structures printed from the personalized hydrogel. Scale bars: (b) = 0.5 cm, (e) = 1 mm, (f) = 100 µm, (g,h) = 1 cm.CC BY · PubMed Central
Figure 6 Printing thick vascularized tissues. a) A top view of a lumen entrance (CD31; green) in a thick cardiac tissue (actinin; pink). b) A model of a tripod blood vessel within a thick engineered cardiac tissue (coordinates in mm), and c) the corresponding lumens in each indicated section of the printed structure. d) Tissue perfusion visualized from dual viewpoints. e–k) A printed small‐scaled, cellularized, human heart. e) The human heart CAD model. f,g) A printed heart within a support bath. h) After extraction, the left and right ventricles were injected with red and blue dyes, respectively, in order to demonstrate hollow chambers and the septum in‐between them. i) 3D confocal image of the printed heart (CMs in pink, ECs in orange). j,k) Cross‐sections of the heart immunostained against sarcomeric actinin (green). Scale bars: (a,c,h, i,j) = 1 mm, (g) = 0.5 cm, (k) = 50 µm.
Figure 6 Printing thick vascularized tissues. a) A top view of a lumen entrance (CD31; green) in a thick cardiac tissue (actinin; pink). b) A model of a tripod blood vessel within a thick engineered cardiac tissue (coordinates in mm), and c) the corresponding lumens in each indicated section of the printed structure. d) Tissue perfusion visualized from dual viewpoints. e–k) A printed small‐scaled, cellularized, human heart. e) The human heart CAD model. f,g) A printed heart within a support bath. h) After extraction, the left and right ventricles were injected with red and blue dyes, respectively, in order to demonstrate hollow chambers and the septum in‐between them. i) 3D confocal image of the printed heart (CMs in pink, ECs in orange). j,k) Cross‐sections of the heart immunostained against sarcomeric actinin (green). Scale bars: (a,c,h, i,j) = 1 mm, (g) = 0.5 cm, (k) = 50 µm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Members W. G., 2017, Circulation, 135, e146

Cited by

See all 1,042

Metadata

Authors
Noor, N., Shapira, A., Edri, R., Gal, I., Wertheim, L., & Dvir, T.
Affiliations
Tel Aviv University (IL)
Corresponding author
Dvir, Tal
Venue
Advanced Science
Publisher
Wiley
Published
2019-04-15
Volume
6
Issue
11
Pages
1900344-1900344
ISSN
2198-3844 (ISSN-L)
OpenAlex
W2937820813
Cited by
1,042
References
36
Citations by year
2026: 59 · 2025: 106 · 2024: 126 · 2023: 187 · 2022: 157 · 2021: 212 · 2020: 142 · 2019: 51
FWCI
49.47
Type
journal article
Language
en
Open access
Locations
  • Advanced Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • European Research Council (637943)
  • Israel Science Foundation (700/13)
  • Ministry of Science, Technology and Space (3‐12587)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
3D bioprinting, cardiac tissue engineering, personalized medicine, pluripotent stem cells, cardiomyocytes, endothelial cells, extracellular matrix hydrogel, bioinks, cardiac cell transplantation, drug screening, organ printing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.